Cure8 research brief
Findings suggest GM-CSF signaling may help limit epithelial injury and shape immune cell states in Crohn’s disease, which could be relevant to understanding inflammation and future therapies targeting innate immunity or ILC–myeloid interactions.
Researchers studying immune pathways, single-cell/spatial transcriptomics, or GM-CSF biology; clinicians interested in translational IBD research; scientists working on innate lymphoid cells or myeloid cell signaling.
This preprint reports single-cell spatial transcriptomics (Xenium) in ileal tissue from Crohn’s disease and functional experiments in a csf2rb-/- zebrafish model and recombinant human GM-CSF treatment.
The authors found GM-CSF enriched in ulcerated regions, associated with STAT5 phosphorylation in macrophage aggregates, and that loss of GM-CSF signaling worsened epithelial injury while recombinant GM-CSF limited damage and affected ILC-like cell populations.
Cross-species single-cell analysis identified conserved ILC-like transcriptional states and GM-CSF–responsive myeloid programs. The work is presented as an abstract and preprint (bioRxiv) and includes spatial single-cell data plus animal-model experiments rather than clinical trial results.
It suggests a protective role for GM-CSF in intestinal inflammation and highlights cell-type–specific spatial signaling patterns that may be relevant to Crohn’s disease pathobiology. This is a research-focused preprint; it does not provide clinical recommendations or human trial evidence for GM-CSF treatment in patients.
If you’re interested in the detailed methods, datasets, or cross-species analyses, consult the full preprint on bioRxiv.
This is a preprint (not peer-reviewed) reporting basic-science and animal-model results. It does not demonstrate safety or efficacy of GM-CSF therapy in people with Crohn’s disease. Cross-species and spatial single-cell findings are hypothesis-generating and need clinical validation.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The finding links a specific mucus-associated protein (HMGB1) to barrier defects in Crohn’s disease, which could help explain how bacteria reach and inflame tissue in active lesions and point to future biomarker or...
Identifies a molecule (CCL3) linked to more severe inflammation in IBD tissues, which could help researchers develop new biomarkers or treatments targeting immune-cell recruitment and polarization.
The study highlights GM‑CSF as a spatial regulator of myeloid–lymphoid interactions in ulcerated ileal tissue, which may help researchers and clinicians understand mechanisms that drive inflammation and epithelial injury...
